Kotak Mahindra Capital Co.Ltd.
Axis Capital Ltd.
Goldman Sachs (India) Securities Pvt.Ltd.
Jefferies India Pvt.Ltd.
JP Morgan India Pvt.Ltd.
UBS Securities India Pvt.Ltd.
DBS Bank India Ltd.
Manipal Health Enterprises Limited, established in 2010 as part of the well-known Manipal Group founded by T. M. A. Pai, is one of India’s leading healthcare providers. The organization offers a broad range of medical services, including specialized care for heart health, cancer treatment, nerve disorders, bone care, and organ transplants. Backed by modern medical technology and skilled medical professionals, the company focuses on delivering high-quality, patient-centered care and growing its presence across the country through strategic partnerships and ongoing facility improvements.
By March 2026, the company’s network grew to include 49 hospitals with more than 13,000 beds, alongside 21 regional clinics. Supported by a dedicated workforce of over 24,000 full-time staff—including thousands of nurses, medical assistants, and administrative team members—Manipal Health continues to expand access to reliable healthcare and modern digital health services for patients nationwide.
For the year/period ended (Rs. in Cr.)
| FY26 | FY25 | FY24 | |
|---|---|---|---|
| Total Revenue | 10520.52 | 8362.79 | 6265.17 |
| Profit After Tax | 916.52 | 1081.67 | 533.20 |
| EPS | 7.71 | 9.25 | 5.27 |
| EBITDA Margin (%) | 26.58 | 26.87 | 28.36 |
| PAT Margin (%) | 8.71 | 12.93 | 8.51 |
For year/ period ended ( in Cr.)
| Company Name | Market Cap (Cr.) | Price | P/BV | P/E | Sales (Cr.) FY26 |
Net Profits(Cr.) FY26 |
|---|---|---|---|---|---|---|
| Manipal Health Enterprises Limited | 77605.68* | 590 | 8.13 | 84.65 | 10520.52 | 916.52 |
| Apollo Hospitals Enterprise Limited | 127130 | 8842 | 13.3 | 65.0 | 25228 | 2003 |
| Fortis Healthcare Ltd | 71117 | 942 | 7.25 | 67.4 | 9128 | 1064 |
| Max Healthcare Institute Limited | 108974 | 1120 | 10.2 | 73.4 | 8373 | 1442 |
*Market cap @upper band
The Company MANIPAL HEALTH ENTERPRISES LIMITED IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
At the upper band of IPO Rs. 590, the stock is valued at 84.65 P/E multiple. Hence, well-informed investors would wait to subscribe for medium to long term perspective.